Rating Change
Barclays analysts initiated coverage on Bausch + Lomb Corporation (NYSE:BLCO) with a rating of Overweight on October 07, 2026.
new coverageNYSE:BLCO
Barclays Initiates Coverage on Bausch + Lomb Corporation (BLCO) with Overweight
Barclays analysts initiated coverage on Bausch + Lomb Corporation (NYSE:BLCO) with a rating of Overweight on October 07, 2026.
At publication ·
What changed
Bausch + Lomb Corporation (NYSE:BLCO) · new coverage
- Firm
- Barclays
- Rating
- Overweight
- Price at event
- $17.32
- Market capitalization
- $6.1B
At a glance
Key takeaways
- Barclays initiated Overweight coverage on Bausch + Lomb (BLCO) on October 7, 2026, while the stock trades at $17.32 with a $6.1B market cap.
Market Context
Bausch + Lomb Corporation operates in the Healthcare sector. The stock currently trades at $17.32 with a market capitalization of $6.1B. The stock has gained 19.1% over the past 52 weeks.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Bausch + Lomb Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Bausch + Lomb Corporation
Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 07, 2026 | Barclays | Overweight | N/A |
| Sep 15, 2026 | Needham | Hold | N/A |
| Sep 09, 2026 | Leerink Partners | Outperform | N/A |
| Aug 28, 2026 | HC Wainwright & Co. | Buy | N/A |
| Aug 03, 2026 | HC Wainwright & Co. | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View BLCO Stock Page
Frequently Asked Questions
What does the Overweight rating mean for BLCO?
A rating of Overweight from Barclays reflects the analyst's outlook on Bausch + Lomb Corporation (NYSE:BLCO). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the BLCO forecast page.